10x Genomics's market cap is currently $1.41B. The company's EPS TTM is $-1.517; its P/E ratio is ―; 10x Genomics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 610.78M	$ 618.73M	$ 516.41M	$ 490.49M	$ 298.85M
Gross Profit	$ 414.48M	$ 409.31M	$ 396.02M	$ 416.40M	$ 240.38M
Operating Income	$ -194.56M	$ -194.95M	$ -167.94M	$ -52.91M	$ -85.32M
EBITDA	$ -194.56M	$ -205.11M	$ -128.49M	$ -24.59M	$ -513.77M
Net Income	$ -182.63M	$ -255.10M	$ -166.00M	$ -58.22M	$ -542.73M
Balance Sheet
Cash & Short-Term Investments	$ 393.40M	$ 388.69M	$ 429.98M	$ 587.45M	$ 663.60M
Total Assets	$ 918.64M	$ 965.14M	$ 1.03B	$ 1.02B	$ 929.34M
Total Debt	$ 82.61M	$ 95.37M	$ 95.18M	$ 81.98M	$ 62.98M
Net Debt	$ -261.45M	$ -263.91M	$ -124.57M	$ -505.47M	$ -600.63M
Total Liabilities	$ 208.50M	$ 224.10M	$ 223.24M	$ 201.26M	$ 190.27M
Stockholders' Equity	$ 710.13M	$ 741.04M	$ 805.74M	$ 817.57M	$ 739.07M
Cash Flow
Free Cash Flow	$ -5.73M	$ -64.72M	$ -165.27M	$ -122.65M	$ -256.29M
Operating Cash Flow	$ 6.66M	$ -15.20M	$ -33.61M	$ -21.37M	$ -217.90M
Investing Cash Flow	$ -32.63M	$ 133.49M	$ -350.89M	$ -106.73M	$ -38.39M
Financing Cash Flow	$ 10.91M	$ 13.67M	$ 15.82M	$ 35.30M	$ 468.91M

Currency in USD

10x Genomics Earnings and Revenue History

Income Statement >

10x Genomics Debt to Assets

Balance Sheet >

10x Genomics Cash Flow

Cash Flow >

10x Genomics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing